drugset / Trial / NCT02100007
ME-344 Given in Combination With Hycamtin® in Patients With Solid Tumors
NaSingle-groupOpen-labelTreatment
Summary
The purpose of this study is to determine the safety and tolerability of ME-344 when given in combination with Hycamtin® in patients with solid tumors
Timeline
- Start
- 2014-04
- Primary completion
- 2016-01
- Completion
- 2016-04
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | ME-344 | Small molecule | 10 mg/kg | Intravenous |
| Subject | Topotecan | Small molecule | 4 mg/m2 | Intravenous |